Keywords: Reckitt Benckiser, Suboxone tablets, Pediatric concerns, Discontinuation, USA, FDA

Reckitt Benckiser Pharma to voluntarily discontinue Suboxone tablet supply in USA

Article | 26 September 2012

Print This

In response to a number of queries from stakeholders, the pharmaceutical unit of conglomerate Reckitt Benckiser (LSE: RB) confirms that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in